Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.

BALANCE investigators and collaborators, Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, Morriss R, Alder N, Juszczak E.

Lancet. 2010 Jan 30;375(9712):385-95. doi: 10.1016/S0140-6736(09)61828-6. Epub 2010 Jan 19.

PMID:
20092882
2.

Efficiency and safety of oxcarbazepine in mood disorders: a naturalistic study exploring the interest of plasma dosages.

Misdrahi D, Tournier M, Droulout T, Grolleau A, Titier K, Molimard M, Verdoux H.

Eur Psychiatry. 2008 Sep;23(6):409-12. doi: 10.1016/j.eurpsy.2008.05.003. Epub 2008 Aug 27.

PMID:
18755575
3.

Agreement between self-rated and clinically assessed symptoms in subjects with psychosis.

Liraud F, Droulout T, Parrot M, Verdoux H.

J Nerv Ment Dis. 2004 May;192(5):352-6.

PMID:
15126889
4.

Is the intensity of Schneiderian symptoms related to handedness and speech disorder in subjects with psychosis?

Verdoux H, Liraud F, Droulout T, Theillay G, Parrot M, Franck N.

Schizophr Res. 2004 Apr 1;67(2-3):167-73.

PMID:
14984875
5.

[Relationships between insight and medication adherence in subjects with psychosis].

Droulout T, Liraud F, Verdoux H.

Encephale. 2003 Sep-Oct;29(5):430-7. French.

PMID:
14615692
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk